{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:27:12Z","timestamp":1787758032316,"version":"build-2784847793"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,6]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>The main objective of the present study is to find out the loose links between prescription of medication and its utilization in the pediatric department, especially with drugs that belong to the antiepileptic medication category.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology:<\/jats:title>\n                    <jats:p>This prospective observational study was carried out for 6 months in the Department of Pharmacy Practice, Tertiary Care Hospital, Bangalore. The study was conducted on 100 patients receiving antiepileptic medication. The patient demographics and all medically relevant information were noted in a predefined data collection form.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The study showed that the maximum number of patients receiving antiepileptic medication belongs to the age group of 2\u20136 years. While comparing the prevalence of ADR levetiracetam, phenytoin and clobazam were identified which are associated with ADR. The highly prescribed drug was valproic acid and carbamazepine. The ADRs documented were loss of appetite, vomiting, anemia, and Steven\u2013Johnson syndrome. Evaluation of prescription was performed, which is a major factor in drug-related ADRs. In the discussion part, various methods of improvement in the prevention of ADRs due to prescription error have been suggested which can improve drug utilization and precaution. An economic study was done in the end to put a light on the cost-effective treatment therapy which might improve patient adherence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>It was concluded that valproic acid was a highly prescribed drug and carbamazepine was the second-most prescribed drug. It was found that majority of prescription was without a generic name and with inappropriate abbreviations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jfmpc.jfmpc_542_21","type":"journal-article","created":{"date-parts":[[2022,6,30]],"date-time":"2022-06-30T10:17:00Z","timestamp":1656584220000},"page":"2393-2398","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Drug utilization study of antiepileptic drugs in the pediatric department, tertiary care hospital, Bangalore, India"],"prefix":"10.4103","volume":"11","author":[{"given":"Zahra","family":"Khoshdel","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice, Karnataka College of Pharmacy, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shibi","family":"Tomas","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Karnataka College of Pharmacy, Bengaluru, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marziye","family":"Jafari","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Faculty of Pharmacy, Guilan University of Medical Science, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,6,30]]},"reference":[{"key":"B2-20240828","first-page":"237","article-title":"Drug utilization study in diabetology outpatient setting of a tertiary hospital","volume":"35","author":"Sutharson","year":"2003","journal-title":"Indian J Pharmacol"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0165-6147(86)90375-5","article-title":"National drug policies:The need for drug utilization studies","volume":"7","author":"Baksaas","year":"1986","journal-title":"Trends Pharmacol Sci"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2710.1998.00161.x","article-title":"Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs","volume":"23","author":"Yuen","year":"1998","journal-title":"J Clin Pharm Ther"},{"key":"B5-20240828","article-title":"Are colloid solutions essential for the treatment of pediatric trauma or burn patients","author":"Huwer","year":"2012","journal-title":"Review for the Expert Committee on the Selection and Use of Essential Medicines, Violence and Injury Prevention and Disability, Geneva, Switzerland,"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2010.07.004","article-title":"RCTs with new antiepileptic drugs in children:A systematic review of monotherapy studies and their methodology","volume":"91","author":"Weijenberg","year":"2010","journal-title":"Epilepsy Res"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(07)60460-7","article-title":"The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy:An unblinded randomised controlled trial","volume":"369","author":"Marson","year":"2007","journal-title":"Lancet"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/pds.1121","article-title":"Paediatric adverse drug reactions reported in Sweden from 1987 to 2001","volume":"14","author":"Kimland","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1528-1157.1981.tb04327.x","article-title":"Monotherapy or Poly therapy for Epilepsy?","volume":"22","author":"Reynolds","year":"1981","journal-title":"Epilepsia"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1528-1157.1989.tb05476.x","article-title":"Outcome after discontinuation of antiepileptic drug therapy in children with epilepsy","volume":"30","author":"Matricardi","year":"1989","journal-title":"Epilepsia"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"623960","DOI":"10.3389\/fneur.2021.623960","article-title":"Magnetic resonance imaging findings in childhood epilepsy at a tertiary hospital in Kenya","volume":"12","author":"Samia","year":"2021","journal-title":"Front Neurol"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/WNF.0000000000000435","article-title":"A systematic review of seizure-freedom rates in patients with benign epilepsy of childhood with centrotemporal spikes receiving antiepileptic drugs","volume":"44","author":"Gerstl","year":"2021","journal-title":"Clin Neuropharmacol"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1055\/s-0039-1698280","article-title":"Sociodemographic, rationale drug use of antiepileptic drugs among pediatric patients with epilepsy:A prospective study at a tertiary care hospital","volume":"10","author":"Dwajani","year":"2019","journal-title":"J Neurosci Rural Pract"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"178","DOI":"10.4103\/2229-3485.140558","article-title":"Drug utilization pattern in South Indian pediatric population:A prospective study","volume":"5","author":"Thiruthopu","year":"2014","journal-title":"Perspectives in Clinical research"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"697","DOI":"10.13005\/bpj\/1691","article-title":"Drug utilization study in epilepsy in a tertiary care hospital","volume":"12","author":"Chandrarathna","year":"2019","journal-title":"Biomed Pharmacol J"},{"key":"B18-20240828","first-page":"55","article-title":"Utilization pattern of antiepileptic drugs and their adverse effects, in a teaching hospital","volume":"3","author":"Mathur","year":"2010","journal-title":"Asian J Pharm Clin Res"},{"key":"B19-20240828","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0976-0105.139729","article-title":"Drug utilization in pediatric neurology outpatient department:A prospective study at a tertiary care teaching hospital","volume":"5","author":"Bhatt","year":"2014","journal-title":"J Basic Clin Pharm"},{"key":"B20-20240828","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1046\/j.1365-2710.2002.00429.x","article-title":"Drug utilization pattern of anti-epileptic drugs:A pharmacoepidemiologic study in Oman","volume":"27","author":"Hanssens","year":"2002","journal-title":"J Clin Pharm Ther"},{"key":"B21-20240828","doi-asserted-by":"crossref","first-page":"537","DOI":"10.18203\/2319-2003.ijbcp20180670","article-title":"Prescription pattern of antiepileptic drugs in indoor patients at tertiary care hospital in Haryana, India","volume":"7","author":"Narwat","year":"2018","journal-title":"Int J Basic Clin Pharmacol"},{"key":"B22-20240828","first-page":"1436","article-title":"Drug prescribing indicators in primary health care centers in Bahrain","volume":"26","author":"Naseeb","year":"2005","journal-title":"Saudi Med J"}],"container-title":["Journal of Family Medicine and Primary Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_542_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:02:21Z","timestamp":1787756541000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jfmpc.jfmpc_542_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":19,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jfmpc.jfmpc_542_21","relation":{},"ISSN":["2249-4863","2278-7135"],"issn-type":[{"value":"2249-4863","type":"print"},{"value":"2278-7135","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"2021-03-24","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}